Event No. 1

Lunchtime discussion probing some of the regulatory quandaries of the 21st century

Dr Sylvain Mandeville: Director of Bioanalytical Services CPR Pharma Services Pte Ltd.

“Raising the bar of regulatory compliance: Current best practice in bioanalysis”

Dr Mandeville will discuss new trends and future directions such as CFR 21 Part 11 compliance, FDA trends, paperless laboratories, recent White papers that will shape the FDA guidance documents of the future.

Dr Mandeville has worked in the fields of general management, business development, bioanalytical method development and the implementation of quality and laboratory information management systems. Dr Mandeville was Director of Bioanalytical Services at Ricerca Biosciences LLC between 2008 and 2010, Senior Director Bioanalytical Services and Business Development at LAB Research Ltd between 2006 and 2008, a consultant responsible for establishment of a new GLP bioanalytical facility for LAB Research in Hungary between 2004 and 2006, Senior Director at Warnex Analytical/Bioanalytical Services Inc between 2001 and 2004, Head of Bioanalytical Services at Phoenix International Life Sciences between 1999 and 2001, and occupied positions of increasing responsibility at LAB Pharmacological Research International between 1993 and 1999. He holds a PhD in Analytical Chemistry and a BSc in Food Sciences and Agricultural Chemistry from McGill University.

Dr Jean-Marie Houle: Director of Clinical Science Sales and Business Development CPR Pharma Services Pty Ltd.

“Efficient First-In-Human study designs; the standard more than the exception”

Dr Houle will discuss the progression in adaptive clinical trial design, and the associated advantages.

Dr Houle is a pharmacokineticist by training and is an expert in drug development. He has worked in the fields of operations, management, business development, pharmacokinetics, clinical pharmacology and as a consultancy to the pharmaceutical industry. Dr Houle was VP of Clinical Operations at Anapharm between 2007-2010; VP of Research and Development at Chronogen between 2006 and 2007 where he headed up R and D, a consultant to the pharmaceutical industry where he assessed clients PK strategy and evaluated PK/Clinical Pharmacology packages, between 2005 and 2006, Director of PK and Clinical Pharmacology at QLT Inc where his role was key in supporting the regulatory submissions for approval of Visudyne globally between 1998 and 2005 and Director of Scientific Affairs at LAB Pharmacology Research from 1987-1997. He holds a PhD in Pharmaceutical Science and a BSc in Pharmacy from The University of Montreal.

Date: 29 February 2012.
Time: 12pm – 2pm
Location: Aspiration, Matrix at Biopolis
Cost: $30 to Members and $50 for non-members. Individual membership of $50 can be paid at the door or directly online. If you take an individual membership, your money will be returned if your company enrolls as a Corporate Member for $1000 during the same financial year.

Please RSVP before 20 February 2012 to Yvette Flanigan - This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Event No. 2

BioSingapore Networking Event.

Wednesday 29 February 2012 from 18:30 – late.

As always, this networking event will provide a good opportunity for you to mingle and get to know the other members better for potential future linkups and to enhance your professional and personal contact database. It’s a lucky date that won’t come around again until the next leap year.
Contract research organizations’ are set to be the next area of growth in the Biotech industry. This month Mr. Jason Valentine Chief Executive Officer and founder of CPR Australia will give a 20 minute talk on Why Singapore? Jason will briefly discuss why CPR, a contract research company, chose to set up operations in Singapore.
Please join us at:

"B"
One Rochester
8 Rochester Park
Singapore 139219

The event is $30 to Members and $40 for non-members. Individual membership of $50 can be paid at the door or directly online. If you take an individual membership, your money will be returned if your company enrolls as a Corporate Member for $1000 during the same financial year.

Hope to you'll be able to join us; do bring your friends and colleagues.

Please RSVP before 22 February 2012 to Yvette Flanigan - This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Date: 10 October to 12 October 2011

Venue: Amphitheatre, Level 2, Duke-NUS

This symposium focuses on translational medicine, particularly that which involves clinical application of advances in cellular and molecular biology and genetics. The sessions will explore investigational medicine from the vantage point of clinician scientists, and the theme running throughout the entire symposium is that of human investigation.

The objective of this gathering of investigators from throughout Singapore and Duke University is to develop further interactions between these two centers of academic medicine, and catalyze innovative collaborations to advance both the development of translational medicine for all partners and its realization for clinical application and commercialization.

Speakers from Duke University, Duke-NUS, local healthcare and research institutions, as well as the pharmaceutical industry will be sharing their insights.

We welcome all participants to this exciting event, which is designed to provide everyone with an opportunity to engage in discussions. In addition to the formal talks by leading investigators, we would particularly like to point out the workshops on the final day of the program where all attendees are encouraged to participate. 

Registration is free of charge.  

For more information, contact Ms Jacqueline Goh at tel: +65 6601 2275 or email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .